This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lip, G. Y. H. Articles by Lowe, G. D. O. Search for Related Content PubMed PubMed Citation Articles by Lip, G. Y. H. Articles by Lowe, G. D. O. Social Bookmarking                         What's this?

Thrombogenesis in Mitral Regurgitation and Aortic Stenosis

Department of Cardiology, Stobhill Hospital, Glasgow; and the Haemostasis, Thrombosis and Vascular Medicine Unit, University Department of Medicine, Royal Infirmary, Glasgow, Scotland.

Ann Rumley, B.Sc.

Department of Cardiology, Stobhill Hospital, Glasgow; and the Haemostasis, Thrombosis and Vascular Medicine Unit, University Department of Medicine, Royal Infirmary, Glasgow, Scotland.

Francis G. Dunn, M.B.Ch.B., FRCP

Department of Cardiology, Stobhill Hospital, Glasgow; and the Haemostasis, Thrombosis and Vascular Medicine Unit, University Department of Medicine, Royal Infirmary, Glasgow, Scotland.

Gordon D. O. Lowe, M.D., FRCP

Department of Cardiology, Stobhill Hospital, Glasgow; and the Haemostasis, Thrombosis and Vascular Medicine Unit, University Department of Medicine, Royal Infirmary, Glasgow, Scotland.

The exact mechanisms for thrombus formation in patients with valvular heart disease have not been clearly defined. Abnormalities in plasma coagulation factors indicative of a prothrombotic state may in part account for the risk of stroke and thromboembolism in such patients. The aim of this study was, therefore, to determine the effects of mitral regurgitation (MR) and aortic stenosis (AS) on plasma fibrinogen or fibrin D-dimer levels as indices of a thrombogenic (or prothrombotic) state.

A total of 25 patients with valve disease in sinus rhythm were studied: 12 patients (all women; mean age fifty-five years, sem 3.3) with MR; and 13 patients (7 men, 6 women; mean age fifty-seven years, sem 3.5) with AS were studied. Patients with MR had a median plasma fibrinogen that was significantly elevated when compared with female population values (median difference 0.62 g/L; 95% confidence intervals (CI) 0.27 to 1.05, P = 0.0016). However, these patients had a median plasma fibrin D-dimer that was lower than that for population controls (median difference 21 ng/mL; 95% CI 0 to 38, P = 0.05). Patients with aortic valve disease had a median plasma fibrinogen that was significantly increased when compared with population controls (median (continued on next page) difference 0.82 g/L; 95% CI 0.34 to 1.24, P = 0.001). These patients had a plasma fibrin D-dimer level that was similar to population values (median difference 3 ng/mL; 95% CI -25 to 22, P = 0.80).

Patients with MR or AS have higher plasma fibrinogen levels when compared with "normal" population values, suggesting possible hemorheologic abnormalities in these patients. Subjects with MR had lower plasma fibrin D-dimer levels, suggesting lesser intravascular clotting, consistent with clinical echocardiographic studies. Subjects with AS had plasma fibrin D-dimer levels similar to the "normal" population values, suggestive of a different pathophysiological mechanism for thromboembolism. These findings add to an improved understanding of the relationship between clinical observations and the signif icance of plasma fibrinogen and fibrin D-dimer levels in thrombogenesis.

Angiology, Vol. 47, No. 12, 1117-1125 (1996)
DOI: 10.1177/000331979604701201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?